Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    ARST0531
Show Display Options
Rank Status Study
1 Active, not recruiting Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Conditions: Adult Malignant Mesenchymoma;   Adult Rhabdomyosarcoma;   Childhood Alveolar Rhabdomyosarcoma;   Childhood Botryoid-Type Embryonal Rhabdomyosarcoma;   Childhood Embryonal Rhabdomyosarcoma;   Childhood Malignant Mesenchymoma;   Non-Metastatic Childhood Soft Tissue Sarcoma;   Stage I Adult Soft Tissue Sarcoma;   Stage II Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Untreated Childhood Rhabdomyosarcoma
Interventions: Drug: Irinotecan Hydrochloride;   Biological: Dactinomycin;   Drug: Cyclophosphamide;   Drug: Vincristine Sulfate;   Radiation: Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration

Indicates status has not been verified in more than two years